test

Barbara Fiorini Due

@Novo Holdings A S

Latest period2024 - Q3ReportedManaged Assets$2.013BTotal holdings37
Assets growth rate8.55%Assets growth rate (2-Q avg)18.26%Continuous growth in asset value2 quarters

Portfolio positions

This chart displays the top 10 holdings in Novo Holdings A S's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 37 positions.

Assets under management

The assets under management (AUM) of Novo Holdings A S over the past 10 years (40 quarters) show continuous growth in total asset value over the last 2 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.013B in assets, with a quarterly growth rate of 8.55% and a 2-quarter average growth rate of 18.26%. The portfolio is managed by Barbara Fiorini Due, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BABAAlibaba Group Hldg Ltd
Recent Activity
2.64%
$53.148M
500,827 shares@ $106.12 avg price
INSMInsmed Inc
Recent Activity
Decreased -9.41%
2.63%
$52.901M
724,666 shares@ $73.0 avg price
CRNXCrinetics Pharmaceuticals In
Recent Activity
2.54%
$51.1M
1M shares@ $51.1 avg price
CABOCable One Inc
Recent Activity
2.06%
$41.416M
118,403 shares@ $349.79 avg price
AVBPArrivent Biopharma Inc
Recent Activity
Increased 0.36%
1.76%
$35.375M
1.505M shares@ $23.51 avg price
MRUSMerus N V
Recent Activity
Increased 3.71%
1.74%
$34.972M
700,000 shares@ $49.96 avg price
BMRNBiomarin Pharmaceutical Inc
Recent Activity
1.72%
$34.442M
490,000 shares@ $70.29 avg price
CLDXCelldex Therapeutics Inc New
Recent Activity
Increased 13.38%
1.63%
$32.755M
963,663 shares@ $33.99 avg price
ALNYAlnylam Pharmaceuticals Inc
Recent Activity
1.62%
$32.559M
118,383 shares@ $275.03 avg price
PHVSPharvaris N V
Recent Activity
1.59%
$31.947M
1.725M shares@ $18.52 avg price